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To the Editor:
We have observed a growing number of isolates of ciproflaxicinresistant Escherichia coli (CREC) at our rehabilitation hospital. In initial studies, 1-3 we observed that almost all (98%) of the isolates were obtained from the urine; 86% of the patients had spinal-cord injury, and 80% were outpatients. Because the outbreak was limited mainly to the spinalcord-injury outpatients, a retrospective case-control study was conducted to identify risk factors for the spread of the CREC in outpatients with spinal-cord injuries from January to December 1993. Control subjects were spinal-cord-injury outpatients with ciprofloxacin-susceptible E coli bacteriuria who immediately followed each patient with CREC. The variables studied are shown in the Table. The only significant factors that we could identify were previous use of fluoroquinolones and the use of intermittent catheterization. The control group, who used more self-catheterization, may have had less direct contact with medical personnel to obtain urine samples, resulting in less chance of transmission of the resistant strain by the personnel. Transmission occurred equally in the two main clinics.
We were surprised at the lack of supportive evidence of spread of the CREC. At a minimum, we had expected to find that patients acquired CREC at an earlier visit to the clinic on a day attended by patients colonized or infected with the CREC. Only one patient with newly recognized CREC bacteriuria had attended a prior clinic on the same day as a colonized patient. We still assume that transfer was occurring between patients at the two main clinics, because that was their only important common ground. The CREC most likely spread via unrecognized breaks in techniques and unrecognized carriers of the resistant strains. Spread also may have occurred through contamination of wheelchairs, clothing, or the environment. On three occasions, cultures of floors, beds, wheelchairs (wheels, grips, brake handles), and hands of the patients colonized with CREC did not reveal any gramnegative bacilli, suggesting that the environment was not contaminated heavily. Others, however, have found gram-negative bacilli on wheelchairs. 4 A possible explanation for our inability to observe transfer in the clinics may be the complexity of the regulation of the resistance genes for fluoroquinolones. One of the features of bacterial resistance to fluoroquinolones has been the ability to accumulate several mutations affecting both DNA gyrase and bacterial permeability. 5 tectable by routine testing in the clinical laboratory. 5 Our speculation is that such strains may spread among patients and become recognized only when the patients receive fluoroqinolones, the most significant factor associated with CREC colonization. That we may have had such strains in our patients was suggested from in vitro studies of these CREC, in which a wide range of minimum inhibitory concentrations to ciprofloxacin was observed. 3 If low-level resistance occurred and was not detected by the clinical laboratory, these patients could have been colonized for longer periods than we had thought. It would appear that the epidemiology of ciprofloxacin resistance in E coli is complex, and further studies focusing on the nature of the resistance of the E coli, specific sites of acquisition, and colonization might be useful to determine exact reservoirs and mechanisms of spread of resistant strains.
